The Next Glivec? Merck Sues Glenmark In Bid To Protect Januvia From Indian Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Glenmark’s move to sell generics of Januvia and Janumet is being legally challenged by Merck and Sun Pharma, with Section 3 (d) of the Indian Patent Act likely to play a critical role in determining who wins and who loses. Is a Glivec-like battle shaping up?